Publications by authors named "D Petullo"

Claim this Profile
E
Exposure to Budesonide, Glycopyrronium, and Formoterol With a Next-Generation Propellant Does Not Exceed Exposure With Hydrofluoroalkane-134a Propellant When Administered Via Pressurized Metered-Dose Inhaler With a Spacer.
Hitesh Pandya, Mehul Patel, Michael Gillen, Jitendar Reddy, Artur Bednarczyk, David Petullo

Clin Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Double-Blind Crossover Study of Change in Post-Dose Lung Function with Hydrofluoroolefin-1234ze, a Next-Generation Propellant for Metered Dose Inhalers, in Participants with Asthma.
Roy A Pleasants, Alan S Bell, Mandeep Jassal, John Xu, David Petullo

J Aerosol Med Pulm Drug Deliv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of budesonide/glycopyrronium/formoterol fumarate dihydrate delivered by HFO-1234ze versus HFA-134a in chronic obstructive pulmonary disease: a phase 3, multi-site, randomised, double-blind, parallel-group, active-comparator study.
Omar S Usmani, Fernando J Martinez, Hitesh Pandya, Matthew Camiolo, Artur Bednarczyk, David Petullo

EClinicalMedicine· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies for Patients with COPD and Phenotypic Features of Asthma: A Pooled Post Hoc Analysis of KRONOS and ETHOS.
Shigeo Muro, Munehiro Seki, John R Hurst, David Petullo, Jonathan Marshall

Int J Chron Obstruct Pulmon Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of hypothetical strategies in acute pain.
Jinglin Zhong, David Petullo

Pharm Stat· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis